Mountain View, CA, United States of America

Arindrajit Basak

USPTO Granted Patents = 5 

Average Co-Inventor Count = 14.1

ph-index = 3

Forward Citations = 109(Granted Patents)


Company Filing History:


Years Active: 2009-2022

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Arindrajit Basak: Innovator in Pharmaceutical Compounds

Introduction

Arindrajit Basak is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors involved in inflammation.

Latest Patents

Arindrajit holds five patents, with his latest innovations focusing on heteroaryl sulfonamides and CCR2/CCR9. These compounds act as potent antagonists of the CCR2 receptor. Animal testing has demonstrated that these compounds are useful for treating inflammation, a hallmark disease associated with CCR2. The compounds are generally aryl sulfonamide derivatives and are valuable in pharmaceutical compositions, methods for treating CCR2-mediated diseases, and as controls in assays for identifying CCR2 antagonists.

Career Highlights

Arindrajit Basak is currently employed at Chemocentryx, Inc., where he continues to advance his research and development efforts in the pharmaceutical industry. His work has been instrumental in creating innovative solutions for treating various diseases.

Collaborations

Some of his notable coworkers include Solomon Ungashe and Zheng Wei, who contribute to the collaborative environment at Chemocentryx, Inc.

Conclusion

Arindrajit Basak's work in developing CCR2 antagonists showcases his commitment to innovation in the pharmaceutical field. His contributions are paving the way for new treatments that address critical health issues related to inflammation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…